Bank Of America CORP De Rotates From Long-Duration Tech to Global Growth and Credit

The biggest dollar adds are not stock-picking trophies; they are deliberate factor and duration tilts.

• IEMG: A +26.9% add and about $3.25B of incremental capital says they prefer broad emerging markets over developed EAFE right now. With a 40.1% gain vs average cost, they’re pressing a profitable risk-on trade rather than bottom-fishing.
• VUG: A +14.1% increase worth roughly $3.0B signals renewed conviction in US large-cap growth as the right equity beta after a choppy quarter, on a position already well in the money at +119.7% vs cost.
• VCIT: A +39.6% ramp, about $2.78B, into intermediate-term investment-grade corporates at a small mark-to-cost loss (~-3.5%) looks like a classic carry and roll-down trade: lock in spreads before a fuller easing cycle is priced.
• VONG and IUSG: With VONG up +48.5% and IUSG up +21.3% in share count, they’re layering additional US growth factor exposure on top of VUG, moving further away from value and small caps toward mega/mid growth quality.
• JPM, GS, BLK: The adds to JPM (+15.8%, ~$2.63B) and GS (+8.0%, ~$0.40B), alongside a small top-up in BlackRock, show rising comfort with money-center and capital-markets franchises as both rate and spread beneficiaries.
• GOVT, AGG, VGIT: Material increases in GOVT (+20.3%, ~$1.83B), AGG (+29.6%, ~$1.58B), and VGIT (+61.6%, ~$1.88B) round out a bond ladder concentrated in intermediate Treasuries and core aggregate exposure, despite modest unrealized losses, implying they view the rate shock as closer to the end than the beginning.

The sales side is just as thematic: they are funding growth and intermediate credit by raiding long duration, value, and legacy beta sleeves.

• IEFA vs IEMG: IEFA saw a -10.8% cut (~$2.23B out) almost dollar-for-dollar to IEMG’s build, a clean pivot from low-growth developed ex-US (EAFE) to higher-beta EM.
• TLT and BNDX: TLT was slashed -22.4% (about $2.12B) and BNDX -11.6% (~$0.79B), both with double-digit or mid-single-digit losses to cost. That’s a clear statement that they no longer want concentrated long-duration and unhedged global bond risk; they prefer the shorter/intermediate curve and mostly USD credit.
• QQQ and IWD: Cuts of -11.7% each in QQQ ($1.32B) and IWD ($1.31B) illustrate the factor rotation: away from Nasdaq-heavy tech beta and broad US value toward more targeted growth baskets like VUG/VONG/IUSG and more idiosyncratic single-name tech.
• IVV, VTV, IWM, VB: Trims in S&P 500 (IVV -7.5%), value tilt (VTV -3.3%), and US small caps (IWM -4.9%, VB -7.7%) show they’re de-emphasizing generic beta and size factors to make room for more intentional growth and EM tilts.
• XOM, JNJ, ABBV, TSLA, WMT, AAPL, MSFT: The cuts here are modest relative to position size; these look like cash harvests from long-held, highly profitable, lower-conviction edges rather than real thesis reversals.

Under the hood, sector rotation is subtle on the surface but sharp at the theme level. The headline tech weight barely budges, yet the character of risk clearly shifts.

Technology remains dominant at 25.6% of the book, just slightly down from 25.98%, but that stability hides a move from generic Nasdaq exposure (QQQ) and broad growth indices (IWF) toward more curated growth sleeves (VUG, VONG, IUSG) and marquee compounders like Nvidia and Broadcom. Nvidia itself was nudged up another +2.1% in shares, while Alphabet was delicately trimmed, underscoring a preference for AI infrastructure and high-margin platforms over ad-heavy megacaps at the margin.

Financials tick up from 4.67% to 5.11%, centered on JPM, Goldman Sachs, and BlackRock — effectively a call that the capital stack (loans, IB, asset management fees) will benefit from a more benign rate and credit backdrop. Energy, health care, and industrials all drift lower as XOM, JNJ, ABBV, and TSLA are trimmed, pushing the capital saved into growth equity and fixed income.

The elephant in the room is the 52.66% “unclassified” bucket, which is largely ETFs. Inside that, the gravity has shifted decisively from value and small caps (VTV, IWD, VB) and long-duration bonds (TLT, BNDX) toward EM equity (IEMG, VWO), US growth (VUG, VONG, IUSG), and intermediate/aggregate bond vehicles (VCIT, VGIT, GOVT, AGG, VCSH).

Taken together, the quarter’s moves point to a house view of slower but positive nominal growth, easing rates, and ongoing equity leadership from quality growth and EM.

If they feared a deep recession, you would expect wholesale de-risking and a rush into long Treasuries, yet they are cutting TLT and BNDX and redistributing into intermediate IG credit and core aggregate exposure at small losses. That’s consistent with a softer-landing or “higher-but-not-breaking” rate regime where carry and roll-down matter more than pure duration convexity.

On the equity side, the bias is clearly for growth over value, EM over stodgy developed ex-US, and targeted factor exposure over plain-vanilla beta. The modest trims in mega-cap tech, energy, and health care look like risk-budget housekeeping, not thesis abandonment; Nvidia, Broadcom, Meta, and Amazon remain fully in the circle of trust.

Going forward, expect further refinement along these lines: incremental adds to EM and growth if volatility offers better entry points, and continued migration of the bond sleeve from global and long-dated paper into USD-centric, intermediate IG credit. This book is positioned not for a new bull-market melt-up, but for a long, grindy mid-cycle phase where factor selection, carry, and duration management drive returns more than simple index exposure.